Since being FDA approved in 2012, Eliquis has become an excellent option for the prevention of stroke in patients with nonvalvular atrial fibrillation. Eliquis was approved based on the results of the 2011 ARISTOTLE Trial. During this trial, over 18,000 patients were studied. Eliquis was compared to Warfarin over a mean period of 1.8 years. During this study Eliquis was shown to be superior to Warfarin in reducing risk of stroke. Patients taking Eliquis also showed significantly less risk for major bleeding compared to Warfarin.
After isolation from the digitalis plant, the medication digoxin was first used in the 1930’s to treat a variety of heart conditions in both pill and intravenous form. Digoxin remains one of the most frequently prescribed drugs in the management of atrial fibrillation.
When a patient goes online and searches about magnesium and AFib, they will find an abundance of information on its use. There are several web pages promoting magnesium use as a natural treatment for atrial fibrillation in addition to promoting several over the counter supplements for magnesium. But what does the data show? Is there any medical literature that says magnesium is beneficial for atrial fibrillation?